Unknown

Dataset Information

0

Rapamycin decreases DNA damage accumulation and enhances cell growth of WRN-deficient human fibroblasts.


ABSTRACT: Werner syndrome (WS), caused by mutations at the WRN helicase gene, is a progeroid syndrome characterized by multiple features consistent with accelerated aging. Aberrant double-strand DNA damage repair leads to genomic instability and reduced replicative lifespan of somatic cells. We observed increased autophagy in WRN knockdown cells; this was further increased by short-term rapamycin treatment. Long-term rapamycin treatment resulted in improved growth rate, reduced accumulation of DNA damage foci and improved nuclear morphology; autophagy markers were reduced to near-normal levels, possibly due to clearance of damaged proteins. These data suggest that protein aggregation plays a role in the development of WS phenotypes and that the mammalian target of rapamycin complex 1 pathway is a potential therapeutic target of WS.

SUBMITTER: Saha B 

PROVIDER: S-EPMC4032596 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC5574180 | biostudies-literature
| S-EPMC1586178 | biostudies-literature
| S-EPMC4934901 | biostudies-literature
| S-EPMC6223735 | biostudies-literature
| S-EPMC4122284 | biostudies-literature
| S-EPMC6060207 | biostudies-literature
| S-EPMC517871 | biostudies-other
| S-EPMC7507383 | biostudies-literature
| S-EPMC3704531 | biostudies-literature
| S-EPMC6850408 | biostudies-literature